Clinical trial
Effects of Optimized Antiplatelet Treatment After Percutaneous Coronary…
NCT00404781 · Shenyang Northern Hospital, Other · Completed
Key facts
| NCT number | NCT00404781 |
|---|---|
| Title | Effects of Optimized Antiplatelet Treatment After Percutaneous Coronary Intervention |
| Official title | Pilot Study of Personal Optimized Antiplatelet Treatment After Percutaneous Coronary Intervention in Patients With Acute Coronary Syndromes |
| Lead sponsor | Shenyang Northern Hospital, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Ischemic Heart Disease, Acute Coronary Syndromes |
| Intervention type | Drug |
| Interventions | cilostazol in addition to aspirin and clopidogrel |
| Enrollment | 305 |
| Start date | Jun 1, 2006 |
| Primary completion | Jun 1, 2007 |
| Completion | Jun 1, 2007 |
| First posted | Nov 29, 2006 |
| Last update posted | Oct 14, 2009 |
| Countries | China |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: